Skip to content

Mary D. Chaglassian, MD

NPI 1417902040ActiveIndividual· Internal Medicine· Elmhurst, NY

Internal Medicine (MD) in Elmhurst, New York, licensed in NY, with an NPI issued in May 2006. Part D covered 170 prescriptions written in 2024, 79% of them generic. Gilead Sciences, Inc. was the largest of 3 companies reporting payments in 2025, $806.64 in all, mostly food and beverage.

Overview

NPI1417902040
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedMay 23, 2006
Last updated in NPPESJul 13, 2026

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine Primary207R00000X180668NY

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)170 · 297 30-day fills
Patients35
Total drug cost$78,438
Generic share79% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$806.64 · 35 payments from 3 companies
  • 2024$621.98 · 25 payments from 8 companies

Top paying companies in 2025

CompanyAmountPayments
Gilead Sciences, Inc.$366.7420
Viiv Healthcare Company$362.3312
Novo Nordisk Inc$77.573

What the 2025 payments were for

  • Food and Beverage$806.64 · 35 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other internal medicine physicians in Elmhurst

All 164 internal medicine physicians in Elmhurst · All internal medicine physicians in New York